NeoGenomics (NEO) Reports In-Line Q1 EPS ; Offers Guidance
Get Alerts NEO Hot Sheet
Join SI Premium – FREE
NeoGenomics (NASDAQ: NEO) reported Q1 EPS of $0.01, in-line with the analyst estimate of $0.01. Revenue for the quarter came in at $187 million versus the consensus estimate of $184.53 million.
GUIDANCE:
NeoGenomics sees FY2026 revenue of $797-803 million, versus the consensus of $796.6 million.
For earnings history and earnings-related data on NeoGenomics (NEO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Updates US Conviction List Director's Cut
- enVVeno Medical (NVNO) Misses Q3 EPS by 302c
- University Bancorp acquires remaining 20% of UIF for $15.2M
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share